D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
FNB Corp
FNB
$6.73B
| $1.4M | ﹤0.01% |
132,149
-42,665
| -24% | -$491K |
|
2352
PUT
Archer Daniels Midland
ADM
$38.2B
| $1.4M | ﹤0.01% |
+32,400
| New | +$1.39M |
|
|
UCTT
2353
PUT
Ultra Clean Holdings
UCTT
$3.73B
| $1.4M | ﹤0.01% |
135,000
-2,500
| -2% | -$26.8K |
|
2354
Helmerich & Payne
HP
$3.45B
| $1.39M | ﹤0.01% |
25,101
-361,304
| -94% | -$19.7M |
|
2355
PUT
Range Resources
RRC
$9.38B
| $1.39M | ﹤0.01% |
123,600
+72,800
| +143% | +$790K |
|
|
ANAT
2356
PUT
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.39M | ﹤0.01% |
+11,500
| New | +$1.58M |
|
|
SBNY
2357
DELISTED
Signature Bank
SBNY
| $1.39M | ﹤0.01% |
10,841
-58,217
| -84% | -$7.41M |
|
2358
Generac Holdings
GNRC
$11.6B
| $1.38M | ﹤0.01% |
26,994
-3,500
| -11% | -$183K |
|
2359
Stock Yards Bancorp
SYBT
$2.64B
| $1.38M | ﹤0.01% |
40,917
-1,136
| -3% | -$39.7K |
|
|
PDCE
2360
CALL
DELISTED
PDC Energy, Inc.
PDCE
| $1.38M | ﹤0.01% |
34,000
+21,500
| +172% | +$785K |
|
|
LBY
2361
DELISTED
Libbey, Inc.
LBY
| $1.38M | ﹤0.01% |
486,781
+9,052
| +2% | +$38.8K |
|
2362
PUT
Tronox
TROX
$932M
| $1.38M | ﹤0.01% |
105,000
| – | – |
|
|
AMWD
2363
PUT
DELISTED
American Woodmark
AMWD
| $1.38M | ﹤0.01% |
16,700
-24,700
| -60% | -$1.85M |
|
2364
PUT
LyondellBasell Industries
LYB
$20B
| $1.38M | ﹤0.01% |
+16,400
| New | +$1.42M |
|
2365
Becton Dickinson
BDX
$45.6B
| $1.38M | ﹤0.01% |
5,653
-34,568
| -86% | -$8.17M |
|
|
MRO
2366
CALL
DELISTED
Marathon Oil Corporation
MRO
| $1.38M | ﹤0.01% |
+82,400
| New | +$1.35M |
|
2367
First Majestic Silver
AG
$7.41B
| $1.38M | ﹤0.01% |
209,050
-147,145
| -41% | -$921K |
|
|
ALE
2368
DELISTED
Allete
ALE
| $1.37M | ﹤0.01% |
16,692
-28,533
| -63% | -$2.25M |
|
2369
IMAX
IMAX
$2.62B
| $1.37M | ﹤0.01% |
60,549
+13,773
| +29% | +$294K |
|
|
GTS
2370
CALL
DELISTED
Triple-S Management Corporation
GTS
| $1.37M | ﹤0.01% |
63,066
| – | – |
|
2371
Natural Health Trends
NHTC
$14.7M
| $1.37M | ﹤0.01% |
105,604
+26,732
| +34% | +$399K |
|
2372
Bread Financial
BFH
$4.37B
| $1.37M | ﹤0.01% |
9,788
-217,576
| -96% | -$29.6M |
|
|
BRKL
2373
DELISTED
Brookline Bancorp
BRKL
| $1.36M | ﹤0.01% |
94,642
-28,462
| -23% | -$427K |
|
|
MZTI
2374
PUT
The Marzetti Company
MZTI
$2.93B
| $1.36M | ﹤0.01% |
8,700
| – | – |
|
|
CS
2375
DELISTED
Credit Suisse Group
CS
| $1.36M | ﹤0.01% |
116,871
-508,713
| -81% | -$6.07M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.